physiciancomments:

Numbers of physicians have witnessed the effects and experienced the Medsonix treatments first hand. Below are a couple of recent comments.

March 2009
"For the last 10 years, I have been fortunate to watch Medsonix develop and have witnessed the effectiveness and impact on patient’s lives. In short, the Medsonix Therapy System works. UNLV studies have proven it is not a placebo effect. In fact, it statistically substantiates an increase of blood flow and mobility. Over the years I have referred many patients to Medsonix.  Numerous patients experienced an immediate and sustained relief from the discomforts attributable to neuropathy. Others have realized a significant improvement of mobility. It reduces pain and inflammation, as well as improves motion for people who have non-degenerative joint arthritis. For people who suffer from poor peripheral blood flow, like PAD and Atherosclerosis, MTS undeniably increases blood flow to the feet and hands. This type of result was not possible before the use of MTS, without having to either stop smoking, increase levels of vigorous exercise or invasive surgery of some type. The technology has a definite positive effect, with no negative side effects or drug interactions whatsoever.”
Dr. Todd Zang, Podiatrist, Las Vegas, NV  

_________________________________________

March 2009
 “My wife and I both experienced a Medsonix treatment first hand. Both of us realized a beneficial relief from pain. My wife suffered from numbness of the feet and lower legs. A couple of days later, due to the improvement of her circulation, she realized a distinct improvement. As for myself, I suffered from tennis elbow for some time, yet after a 30 minute Medsonix treatment I am pleased to report I recognized significant relief from pain.” Dr Charles Lane, Chiropractor, Dallas, Texas

MEDICAL DISCLAIMER: Medsonix, Inc makes no claims, representations or warranties to healing of any physical or emotional ailments. Medsonix does not diagnose, treat, cure or prevent any disease. The FDA has not evaluated this process.